Clinical diagnostic biomarker "circulating tumor cells" in breast cancer - a meta-analysis.
Frontiers in oncology(2023)
Abstract
In meta-regressions and subgroup analysis, potential heterogeneity factors were analyzed, but the source of heterogeneity is still unclear. CTCs, as a novel tumor marker, have a good diagnostic value, but its enrichment and detection methods still need to continue to be developed to improve detection accuracy. Therefore, CTCs can be used as an auxiliary means of early detection, which is helpful to the diagnosis and screening of breast cancer.
MoreTranslated text
Key words
clinical diagnostic biomarker,breast cancer,circulating,tumor cells”,meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined